EUVIMEDEUVIMED entdecken
Crossref

Patient Preferences on Clinical Decision Making in Multiple Myeloma

Ghulam Rehman Mohyuddin iD, Rajshekhar Chakraborty iD, Katherine Berger iD, Ryan Winborg iD, Mason S Barnes, Jorge Arturo Hurtado Martinez iD, Jay R Hydren, Douglas Sborov iD, Amandeep Godara iD, Brian McClune, Christopher M Booth iD, Edward R Scheffer Cliff iD

JCO Oncology Practice · 2026-05 · 22 (5) · 877-882

DOI: 10.1200/op-25-00322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2026-05. Verfasst von Ghulam Rehman Mohyuddin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, Salt Lake City, UT. Hauptthemen laut MEDLINE: Multiple Myeloma, Patient Preference, Clinical Decision-Making. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE To better understand the priorities that guide patients with multiple myeloma, we surveyed patients on four different treatment scenarios, each of treatment strategies shown to improve progression-free survival (PFS) but offering similar overall survival (OS) outcomes. METHODS We conducted a survey using the HealthTree Cure Hub by the HealthTree Foundation, the largest online portal for people with plasma cell dyscrasias. RESULTS The primary analysis cohort included 466 participants with myeloma, while an additional 297 responses from patients with smoldering myeloma or monoclonal gammopathy of uncertain significance were analyzed separately. When presented with either three-drug or four-drug frontline treatment for their myeloma, where four drugs offered better PFS, similar OS, and slightly increased toxicity, 56% of participants chose four drugs. For one-off consolidation treatment after induction, analogous to autologous transplant, which improved PFS but not OS, 50% of participants chose the consolidation. For maintenance therapy, where maintenance with two drugs offered better PFS, but similar OS and increased toxicity than one drug, 17% of participants chose two-drug maintenance. When evaluating a scenario for multiply relapsed disease, where a treatment improved PFS with increased toxicity, and no impact on OS, 7% of participants elected to receive this treatment. CONCLUSION Our findings show that many patients choose not to receive treatments that improve PFS if they do not positively affect OS and lead to substantial clinical, financial, and/or time toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPatient PreferenceClinical Decision-MakingHumansMaleFemaleMiddle AgedAged

Autor:innen und Institutionen

  • Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, Salt Lake City, UT.
  • Division of Hematology, Columbia University, New York, NY.
  • Patient Advocate, Pawcatuck, CT.
  • Brigham Young University, Provo, UT.
  • HealthTree, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT.
  • Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, ON, Canada.

ORCID-Profile: Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Katherine Berger, Ryan Winborg, Jorge Arturo Hurtado Martinez, Douglas Sborov, Amandeep Godara, Christopher M Booth, Edward R Scheffer Cliff

Zitieren

APA

Mohyuddin, G. R., Chakraborty, R., Berger, K., Winborg, R., Barnes, M. S., Hurtado Martinez, J. A., Hydren, J. R., Sborov, D., Godara, A., McClune, B., Booth, C. M., & Cliff, E. R. S. (2026). Patient Preferences on Clinical Decision Making in Multiple Myeloma. JCO Oncology Practice, 22(5), 877-882. https://doi.org/10.1200/op-25-00322

Vancouver

Mohyuddin GR, Chakraborty R, Berger K, Winborg R, Barnes MS, Hurtado Martinez JA, et al. Patient Preferences on Clinical Decision Making in Multiple Myeloma. JCO Oncology Practice. 2026;22(5):877-882. doi:10.1200/op-25-00322

BibTeX
@article{Mohyuddin2026,
  author = {Mohyuddin, Ghulam Rehman and Chakraborty, Rajshekhar and Berger, Katherine and Winborg, Ryan and Barnes, Mason S and Hurtado Martinez, Jorge Arturo and Hydren, Jay R and Sborov, Douglas and Godara, Amandeep and McClune, Brian and Booth, Christopher M and Cliff, Edward R Scheffer},
  title = {Patient Preferences on Clinical Decision Making in Multiple Myeloma},
  journal = {JCO Oncology Practice},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {877--882},
  doi = {10.1200/op-25-00322}
}
Kostenlos starten →